Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 8, 2019
Structure-activity Relationship Study on Therapeutically Relevant EGFR Double Mutant InhibitorsShehnaz Fatima, Subhash M AgarwalFuture Medicinal Chemistry|December 4, 2019
ADMET profiling of geographically diverse phytochemical using chemoinformatic toolsShehnaz Fatima, Payal Gupta, Shilpa Sharma, et al.Bioorganic & Medicinal Chemistry Letters|September 14, 2020
Synthesis of metronidazole based thiazolidinone analogs as promising antiamoebic agentsMohammad Fawad Ansari, Afreen Inam, Kamal Ahmad, et al.Pain and Therapy|June 20, 2024
Effect of Intravenous Sodium Pentobarbital on Pain and Sensory Abnormalities in Patients with Chronic Non-Cancer Pain: Narrative Literature Review, Research Study, and Illustrative Case ReportsShehnaz Fatima Lakha, Angela MailisJournal of Receptor and Signal Transduction Research|September 12, 2018
Unraveling structural requirements of amino-pyrimidine T790M/L858R double mutant EGFR inhibitors: 2D and 3D QSAR studyShehnaz Fatima, Subhash Mohan AgarwalJournal of Receptor and Signal Transduction Research|September 21, 2019
Exploring structural features of EGFR-HER2 dual inhibitors as anti-cancer agents using G-QSAR approachShehnaz Fatima, Subhash Mohan AgarwalChemical Biology & Drug Design|May 30, 2018
Insight into structural requirements of antiamoebic flavonoids: 3D-QSAR and G-QSAR studiesShehnaz Fatima, Payal Gupta, Subhash Mohan AgarwalMicrorna (Shariqah, United Arab Emirates)|July 30, 2014
Identification of critical microRNA gene targets in cervical cancer using network propertiesGarima Sharma, Subhash M AgarwalPain and Therapy|October 25, 2022
Comparison of Older and Younger Patients Referred to a Non-interventional Community Pain Clinic in the Greater Toronto Area (GTA)Shehnaz Fatima Lakha, Demetry Assimakopoulos, Angela MailisChemical Biology & Drug Design|October 15, 2020
TMLRpred: A machine learning classification model to distinguish reversible EGFR double mutant inhibitorsRavi Saini, Shehnaz Fatima, Subhash Mohan AgarwalPageof 5